An Expert’s Perspective on the Emerging Role of Anti-CGRP Monoclonal Abs in Migraine Prevention
Course Director, David W. Dodick, MD, discusses migraine prevention in this CME activity titled "An Expert’s Perspective on the Emerging Role of Anti-CGRP Monoclonal Antibodies in Episodic and Chronic Migraine Prevention." For the full presentation, downloadable practice aids and slides, complete CME information, and to apply for credit, please visit us at http://www.peerview.com/NAB865. CME credit will be available until December 26, 2018.
Видео An Expert’s Perspective on the Emerging Role of Anti-CGRP Monoclonal Abs in Migraine Prevention канала PeerView CME
Видео An Expert’s Perspective on the Emerging Role of Anti-CGRP Monoclonal Abs in Migraine Prevention канала PeerView CME
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Migraine Treatment update - Mathew Robbins, MDWhat Causes Migraine Disease? 5 Factors in Migraine NeurobiologyMigraine and the New Anti-CGRP Treatments: Facebook Live with Dr. David DodickYour CGRP Questions AnsweredVisual Snow Initiative's Personal Stories Series: #4 Owen WardlawHighly Effective Disease-Modifying Therapies for Multiple SclerosisImproving the Diagnosis and Treatment of LupusA New Treatment Era for Light Chain Amyloidosis: Interprofessional LessonsHow do monoclonal antibodies work? Rituximab, infliximab, adalimumab and othersNeuroscientist Explains One Concept in 5 Levels of Difficulty | WIREDSpotlight on Migraine - Episode 16 - The New CGRP Blocking Migraine TreatmentsNew migraine prevention drugs: Mayo Clinic RadioSadhguru Reveal The Secret of his Knowledge | Power of Shiva Shambho Mantra | Mystics of India |2018Parkinson's Disease Treatment -- Mayo ClinicSimplifying New Migraine Treatments: Gepants and Ditans - Spotlight on Migraine S2:Ep7Differentiating Cluster Headaches from other Trigeminal Autonomic CephalalgiaDr. Carrie Dougherty - What is CGRP?Testing and Treatment for Vestibular Migraine - Spotlight on Migraine Season 2, Episode 2The Impact of Migraine: Q&A with Dr. David DodickRecent Advances in the Pharmacologic Management of Idiopathic Hypersomnia